SLHN 📈 Swiss Life Holding - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0014852781
SLHN: Life Insurance, Pensions, Financial Solutions, Asset Management, Investments
Swiss Life Holding AG is a prominent financial services provider, offering a comprehensive suite of life, pensions, and financial solutions tailored to the needs of private and corporate clients. The company's operational scope spans multiple segments, including Switzerland, France, Germany, International, Asset Managers, and Other, allowing it to maintain a diversified presence across various markets. Its product portfolio encompasses a broad range of life, pension, health, annuity, and investment-type policies, catering to both groups and individuals, as well as disability coverage, thereby addressing a wide spectrum of client requirements.
The company's insurance offerings extend to property and casualty, liability and motor, accident, health, and payment protection products, providing clients with a robust risk management framework. Additionally, Swiss Life Holding AG engages in asset management and provides advisory services for institutional clients, leveraging its expertise to deliver customized solutions that meet the unique needs of these clients. Its business interests also encompass private equity, information technology, real estate, finance, banking, reinsurance, brokering, and investment funds, underscoring its commitment to diversification and strategic growth.
Swiss Life Holding AG's distribution strategy relies on a combination of its sales force and distribution partners, enabling the company to effectively reach its target markets and deliver its products to a broad client base. The company operates under several brands, including Swiss Life Select, Tecis, Horbach, Proventus, Chase de Vere, and Fincentrum, each serving as a testament to its brand diversity and market penetration. With a history dating back to 1857, Swiss Life Holding AG is headquartered in Zurich, Switzerland, and has established itself as a stalwart in the financial services industry, with a web presence at https://www.swisslife.com and listed with the ISIN CH0014852781 as a common stock under the GICS Sub Industry classification of Multi-line Insurance.
Additional Sources for SLHN Stock
SLHN Stock Overview
Market Cap in USD | 22,834m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
SLHN Stock Ratings
Growth 5y | 73.3% |
Fundamental | 15.6% |
Dividend | 69.0% |
Rel. Strength Industry | -17.1 |
Analysts | - |
Fair Price Momentum | 749.07 CHF |
Fair Price DCF | - |
SLHN Dividends
Dividend Yield 12m | 4.79% |
Yield on Cost 5y | 8.58% |
Annual Growth 5y | 64.38% |
Payout Consistency | 71.0% |
SLHN Growth Ratios
Growth Correlation 3m | -19.4% |
Growth Correlation 12m | 93.7% |
Growth Correlation 5y | 94.4% |
CAGR 5y | 12.28% |
CAGR/Mean DD 5y | 1.25 |
Sharpe Ratio 12m | 1.22 |
Alpha | 2.08 |
Beta | 0.86 |
Volatility | 17.96% |
Current Volume | 183.1k |
Average Volume 20d | 84.2k |
As of December 21, 2024, the stock is trading at CHF 688.40 with a total of 183,126 shares traded.
Over the past week, the price has changed by +0.32%, over one month by -3.82%, over three months by -2.65% and over the past year by +23.77%.
Neither. Based on ValueRay Fundamental Analyses, Swiss Life Holding is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.62 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLHN as of December 2024 is 749.07. This means that SLHN is currently overvalued and has a potential downside of 8.81%.
Swiss Life Holding has no consensus analysts rating.
According to ValueRays Forecast Model, SLHN Swiss Life Holding will be worth about 810.1 in December 2025. The stock is currently trading at 688.40. This means that the stock has a potential upside of +17.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 713.1 | 3.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 810.1 | 17.7% |